Copyright
©The Author(s) 2021.
World J Hepatol. Dec 27, 2021; 13(12): 2113-2127
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2113
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2113
Figure 1 Aspartate aminotransferase, alanine aminotransferase and gamma-glutamyl transferase levels before and after oral vancomycin treatment (n = 12 patients).
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma-glutamyl transferase; OVT: Oral vancomycin treatment.
Figure 2 Percentage of patients (n = 75) who normalized aspartate aminotransferase and gamma-glutamyl transferase levels before and after oral vancomycin treatment.
AST: Aspartate aminotrasferase; GGT: Gamma-glutamyl trasferase; OVT: Oral vancomycin treatment; AIH: Autoimmune hepatitis; ASC: Autoimmune sclerosing cholangitis.
- Citation: Di Giorgio A, Tulone A, Nicastro E, Norsa L, Sonzogni A, D'Antiga L. Use of oral vancomycin in children with autoimmune liver disease: A single centre experience. World J Hepatol 2021; 13(12): 2113-2127
- URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2113.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2113